Erratum: Corrigendum to “Construction of a highly-active, liver-specific transcriptional regulatory element through combination of the albumin promoter and α-fetoprotein enhancer”(Plasmid (2011) 65(2) (125–131) (S0147619X1000096X) (10.1016/j.plasmid.2010.11.006));Construction of a highly-active, liver-specific transcriptional regulatory element through combination of the albumin promoter and α-fetoprotein enhancer

Plasmid

Volumn 65, Issue 2, 2011, Pages 125-131

  Chen, En Qiang ^a,b   Song, Xue Qin ^a,b   Wang, Ya Li ^a,b   Zhou, Tao You ^a,b   Bai, Lang ^a,b   Liu, Li ^a,b   Liu, Cong ^a,b   Cheng, Xing ^a,b   Tang, Hong ^a,b  

^a SICHUAN UNIVERSITY   (China)

^b SICHUAN UNIVERSITY   (China)

Author keywords

Albumin promoter; Alpha fetoprotein enhancer; Combined element; Liver specific expression

Indexed keywords

ALBUMIN; ALPHA FETOPROTEIN; HEPATITIS B SURFACE ANTIGEN; LUCIFERASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIGEN EXPRESSION; ARTICLE; CONTROLLED STUDY; EMBRYO; ENHANCER REGION; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; IN VITRO STUDY; LIVER; LIVER CELL; MALE; MOLECULAR CLONING; MOUSE; MUSCLE; NONHUMAN; PLASMID; PROMOTER REGION; TISSUE SPECIFICITY; TRANSCRIPTION REGULATION;

EID: 79551494434     PISSN: 0147619X     EISSN: 10959890     Source Type: Journal    
DOI: 10.1016/j.plasmid.2016.10.002     Document Type: Erratum

References (31)

1. Al-Dosari M., et al. Evaluation of viral and mammalian promoters for driving transgene expression in mouse liver. Biochem. Biophys. Res. Commun. 2006, 339:673-678.
2. Bosch, F.X., et al., 2005. Epidemiology of hepatocellular carcinoma. Clin. Liver Dis. 9, 191-211, v.
3. Cao G., et al. Gene therapy for hepatocellular carcinoma based on tumour-selective suicide gene expression using the alpha-fetoprotein (AFP) enhancer and a housekeeping gene promoter. Eur. J. Cancer 2001, 37:140-147.
4. Gehrke S., et al. Chimeric transcriptional control units for improved liver-specific transgene expression. Gene 2003, 322:137-143.
5. He P., et al. The targeted expression of the human interleukin-2/interferon alpha2b fused gene in alpha-fetoprotein-expressing hepatocellular carcinoma cells. J. Cancer Res. Clin. Oncol. 1999, 125:77-82.
6. Herbomel P., et al. The rat albumin promoter is composed of six distinct positive elements within 130 nucleotides. Mol. Cell Biol. 1989, 9:4750-4758.
7. Herweijer H., et al. Time course of gene expression after plasmid DNA gene transfer to the liver. J. Gene Med. 2001, 3:280-291.
8. Hu J.M., et al. Functional analyses of albumin expression in a series of hepatocyte cell lines and in primary hepatocytes. Cell Growth Differ. 1992, 3:577-588.
9. Jin J.R., et al. Enhancer sharing in a plasmid model containing the alpha-fetoprotein and albumin promoters. DNA Cell Biol. 1995, 14:267-272.
10. Kramer M.G., et al. In vitro and in vivo comparative study of chimeric liver-specific promoters. Mol. Ther. 2003, 7:375-385.
11. Lam P.Y., et al. An efficient and safe herpes simplex virus type 1 amplicon vector for transcriptionally targeted therapy of human hepatocellular carcinomas. Mol. Ther. 2007, 15:1129-1136.
12. Liaw Y.F., et al. Asian-Pacific consensus statement on the management of chronic hepatitis B: a 2008 update. Hepatol. Int. 2008, 2:263-283.
13. Liu F., et al. Hydrodynamics-based transfection in animals by systemic administration of plasmid DNA. Gene Ther. 1999, 6:1258-1266.
14. Mikkelsen J.G., et al. Helper-independent sleeping beauty transposon-transposase vectors for efficient nonviral gene delivery and persistent gene expression in vivo. Mol. Ther. 2003, 8:654-665.
15. Miyatake S.I., et al. Hepatoma-specific antitumor activity of an albumin enhancer/promoter regulated herpes simplex virus in vivo. Gene Ther. 1999, 6:564-572.
16. Modi A.A., et al. Complementary and alternative medicine (CAM) for the treatment of chronic hepatitis B and C: a review. Antivir. Ther. 2007, 12:285-295.
17. Papadakis E.D., et al. Promoters and control elements: designing expression cassettes for gene therapy. Curr. Gene Ther. 2004, 4:89-113.
18. Pin, R. H., et al., 2004. Utilizing alpha-fetoprotein expression to enhance oncolytic viral therapy in hepatocellular carcinoma. Ann. Surg. 240, 659-665; discussion 665-6.
19. Pinkert C.A., et al. An albumin enhancer located 10kb upstream functions along with its promoter to direct efficient, liver-specific expression in transgenic mice. Genes Dev. 1987, 1:268-276.
20. Sawadaishi K., et al. Interaction of a hepatoma-specific nuclear factor with transcription-regulatory sequences of the human alpha-fetoprotein and albumin genes. Mol. Cell Biol. 1988, 8:5179-5187.
21. Tronche F., et al. The rat albumin promoter: cooperation with upstream elements is required when binding of APF/HNF1 to the proximal element is partially impaired by mutation or bacterial methylation. Mol. Cell Biol. 1989, 9:4759-4766.
22. Vacher J., Tilghman S.M. Dominant negative regulation of the mouse alpha-fetoprotein gene in adult liver. Science 1990, 250:1732-1735.
23. Weinberg M.S., et al. Specific inhibition of HBV replication in vitro and in vivo with expressed long hairpin RNA. Mol. Ther. 2007, 15:534-541.
24. Wen P., et al. Enhancer, repressor, and promoter specificities combine to regulate the rat alpha-fetoprotein gene. DNA Cell Biol. 1991, 10:525-536.
25. Wooddell C.I., et al. Sustained liver-specific transgene expression from the albumin promoter in mice following hydrodynamic plasmid DNA delivery. J. Gene Med. 2008, 10:551-563.
26. Wu C.H., et al. Evaluation of multicomponent non-viral vectors for liver directed gene delivery. J. Drug Targeting 2002, 10:105-111.
27. Wu Y., et al. Specific anti-viral effects of RNA interference on replication and expression of hepatitis B virus in mice. Chin. Med. J. (Engl) 2005, 118:1351-1356.
28. Xia D., et al. Recent advances in liver-directed gene transfer vectors. Hepatobiliary Pancreat Dis Int. 2004, 3:332-336.
29. Zaret K.S., et al. Conditional enhancement of liver-specific gene transcription. Proc. Natl. Acad. Sci. USA 1988, 85:9076-9080.
30. Zhang D.E., et al. Functional analysis of the trans-acting factor binding sites of the mouse alpha-fetoprotein proximal promoter by site-directed mutagenesis. J. Biol. Chem. 1991, 266:21179-21185.
31. Zhang G., et al. High levels of foreign gene expression in hepatocytes after tail vein injections of naked plasmid DNA. Hum. Gene Ther. 1999, 10:1735-1737.